Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Pliant Therapeutics (PLRX) Preferred Dividend Payments (2019 - 2020)

Pliant Therapeutics (PLRX) has disclosed Preferred Dividend Payments for 2 consecutive years, with $11.0 million as the latest value for Q1 2020.

  • On a quarterly basis, Preferred Dividend Payments changed N/A to $11.0 million in Q1 2020 year-over-year; TTM through Mar 2021 was $2.1 million, a N/A change, with the full-year FY2019 number at -$6.2 million, changed N/A from a year prior.
  • Preferred Dividend Payments was $11.0 million for Q1 2020 at Pliant Therapeutics, up from -$10.3 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $11.0 million in Q1 2020 to a low of -$10.3 million in Q4 2019.